Cited by 1,419

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:Developed in Collaboration With the International Society for Heart and Lung Transplantation

2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE, Jessup, Mariell, Abraham, William T., Casey, Donald E., Feldman, Arthur M., Francis, Gary S., Ganiats, Theodore G., Konstam, Marvin A., Mancini, Donna M., Rahko, Peter S., Silver, Marc A., Stevenson, Lynne Warner, Yancy, Clyde W.·2009·Circulation

DOI 10.1161/circulationaha.109.192064

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.192064

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Self-citation
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
Self-citation
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Self-citation
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Self-citation
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citation
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Self-citation
Rhythm control versus rate control for atrial fibrillation and heart failure
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708789 · Cited by 1,585
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Transitional Care of Older Adults Hospitalized with Heart Failure: A Randomized, Controlled Trial
Naylor, M. D., Brooten, D. A., Campbell, R. L., Maislin, G., McCauley, K. M., & Schwartz, J. S. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52202.x · Cited by 1,365
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
Self-citation
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
Solomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696906 · Cited by 681
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group
Goldstein, R. E., Boccuzzi, S. J., Cruess, D., & Nattel, S. (1991) · Circulation · doi:10.1161/01.cir.83.1.52 · Cited by 521
Clinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation: A Meta-Analysis
Wood, M. A., Brown-Mahoney, C., Kay, G. N., & Ellenbogen, K. A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1138 · Cited by 476
Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.048 · Cited by 257
Self-citation
Calcium channel blockers in heart failure
Elkayam, U. (1998) · Cardiology · doi:10.1159/000047278 · Cited by 69

Research works printed but not linked: 317

ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines. 2006. Available at http://circ.ahajournals.org/manual/. http://www.acc.org/qualityandscience/clinical/manual/pdfs/methodology.pdf and Accessed January 30 2008.
10.1016/j.jacc.2005.02.083 · DOI · Paper page
Jessup M, Abraham WT, Casey DE Jr., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of chronic heart failure in adults with the 2008 focused update incorporated. J Am Coll Cardiol. 2008; 53: e1–90.
10.1161/circ.68.4.6352078 · DOI
10.1161/circ.110.14.e340 · DOI
10.1053/euhj.2000.2289 · DOI · Paper page
10.1016/S0002-9149(04)01055-0 · DOI
10.4065/81.7.906 · DOI
10.1016/j.nuclcard.2004.04.011 · DOI
10.1161/circ.94.12.3176 · DOI
10.1016/S0002-8703(98)70085-7 · DOI
10.1016/j.healun.2006.06.008 · DOI · Paper page
10.1016/S0140-6736(03)13976-1 · DOI · Paper page
10.1016/j.amjcard.2006.06.005 · DOI
10.1016/j.ehj.2004.07.038 · DOI
10.1016/j.ejheart.2003.12.013 · DOI
10.1016/S0735-1097(00)01156-6 · DOI · Paper page
10.1016/j.clinbiochem.2007.08.008 · DOI
10.1016/j.amjcard.2007.06.020 · DOI
10.1016/j.annemergmed.2006.10.024 · DOI
10.1016/S0735-1097(02)02164-2 · DOI · Paper page
The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 96th Edition. Boston MA: Little Brown 1964.
10.1023/A:1023001104207 · DOI
10.1016/0735-1097(95)90027-6 · DOI · Paper page
10.1161/01.cir.0000095029.57483.60 · DOI · Paper page
10.1016/S0140-6736(00)02060-2 · DOI · Paper page
10.1016/S0002-8703(99)70113-4 · DOI · Paper page
10.1054/jcaf.2001.24609 · DOI
10.1056/NEJMoa031681 · DOI · Paper page
10.1016/j.jacc.2003.10.066 · DOI · Paper page
10.1016/j.jacc.2003.05.011 · DOI · Paper page
10.1161/01.cir.0000106903.98196.b6 · DOI
10.1016/0002-9149(89)90912-0 · DOI
10.1161/circ.95.12.2660 · DOI
10.1161/circulationaha.105.584102 · DOI · Paper page
10.1016/j.jacc.2003.08.058 · DOI
10.1016/j.jacc.2006.07.010 · DOI · Paper page
10.1016/j.jacc.2007.09.026 · DOI · Paper page
10.1016/S0735-1097(83)80316-7 · DOI · Paper page
10.1001/jama.1995.03520420066040 · DOI · Paper page
10.1161/circ.70.2.6329547 · DOI
10.1097/00005344-198700003-00021 · DOI
10.1136/hrt.52.5.530 · DOI · Paper page
10.1136/hrt.54.3.305 · DOI · Paper page
Cowley AJ, Rowley JM, Stainer KL, et al. Captopril therapy for heart failure. Lancet. 1982; 2: 730–2.
10.1136/bmj.290.6485.1861 · DOI
10.1161/circ.79.3.2521816 · DOI
10.1093/oxfordjournals.eurheartj.a060844 · DOI
10.1056/NEJM198706043162301 · DOI
10.1016/S0140-6736(98)11181-9 · DOI · Paper page
10.1056/NEJM200105313442202 · DOI · Paper page
10.1016/S0140-6736(03)13800-7 · DOI · Paper page
10.1016/S0140-6736(99)04440-2 · DOI
10.1161/circ.98.12.1184 · DOI
10.1056/NEJM199605233342101 · DOI · Paper page
10.1016/S0140-6736(00)04560-8 · DOI · Paper page
10.1016/S0140-6736(03)13801-9 · DOI · Paper page
10.1016/0735-1097(94)90641-6 · DOI
10.1016/0735-1097(94)90174-0 · DOI · Paper page
10.1016/0735-1097(95)00012-S · DOI · Paper page
10.1161/circ.92.6.1499 · DOI
10.1016/0140-6736(93)92930-R · DOI · Paper page
CIBIS Investigators and Committees. Circulation. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). 1994; 90: 1765–73.
10.1161/circ.94.11.2793 · DOI
10.1161/circ.94.11.2800 · DOI
10.1016/S0140-6736(97)80008-6 · DOI · Paper page
10.1016/S0140-6736(03)14284-5 · DOI · Paper page
10.1161/circ.88.4.8403307 · DOI
10.1161/circ.91.3.691 · DOI
10.1161/circ.100.22.2224 · DOI
10.1016/S0002-9149(99)00646-3 · DOI
10.1161/circ.100.10.1056 · DOI
10.1016/S0167-5273(98)00149-1 · DOI
10.1016/S0735-1097(02)02063-6 · DOI
10.1001/archinte.158.10.1108 · DOI · Paper page
Herchuelz A, Derenne F, Deger F, et al. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance. J Pharmacol Exp Ther. 1989; 248: 1175–81. · DOI
10.1016/0002-9149(92)90733-F · DOI
10.1038/clpt.1991.142 · DOI
10.1056/NEJM198908103210629 · DOI · Paper page
10.1056/NEJM199207233270403 · DOI · Paper page
10.1016/0002-8703(89)90254-8 · DOI
10.1016/j.amjcard.2008.07.016 · DOI
10.1177/0269215507079097 · DOI
10.1016/j.ahj.2007.07.019 · DOI
10.1016/j.ejheart.2005.05.002 · DOI
10.1161/01.cir.0000134957.51747.6e · DOI
10.1161/circulationaha.105.581884 · DOI · Paper page
10.1016/j.cardfail.2006.08.214 · DOI
10.1016/S0735-1097(99)00148-5 · DOI
10.1023/A:1009862028599 · DOI
10.1056/NEJMoa013474 · DOI · Paper page
10.1067/mhj.2000.110088 · DOI
10.1001/jama.288.24.3115 · DOI · Paper page
10.1056/NEJMoa0706695 · DOI · Paper page
10.1056/NEJMoa050496 · DOI · Paper page
10.1016/S0735-1097(03)01042-8 · DOI · Paper page
10.1016/0167-5273(95)02502-2 · DOI · Paper page
10.1016/S0167-5273(99)00077-7 · DOI · Paper page
10.1016/0002-9149(84)90320-5 · DOI · Paper page
10.1161/circ.96.10.3273 · DOI
10.1161/circ.99.12.1567 · DOI
10.1111/j.1540-8159.2000.tb07006.x · DOI
10.1161/circ.102.25.3053 · DOI
10.1001/jama.289.20.2685 · DOI
10.1016/j.jacc.2004.05.055 · DOI · Paper page
10.1053/euhj.2002.3232 · DOI · Paper page
10.1016/S0735-1097(02)01779-5 · DOI · Paper page
10.1001/jama.289.13.1652 · DOI · Paper page
10.1056/NEJMoa040135 · DOI · Paper page
10.1016/j.cardfail.2003.10.012 · DOI
10.1016/S1071-9164(99)90001-5 · DOI
10.1016/j.hrthm.2006.12.003 · DOI
10.1016/j.pcad.2005.09.001 · DOI
10.1056/NEJMoa021375 · DOI · Paper page
10.1001/jama.1988.03720040031022 · DOI · Paper page
10.1136/bmj.1.6063.749 · DOI
10.1056/NEJM198203253061202 · DOI · Paper page
10.1016/0002-9149(88)90947-2 · DOI · Paper page
10.1056/NEJM198903163201101 · DOI · Paper page
10.1016/0735-1097(93)90403-N · DOI · Paper page
10.1056/NEJM199307013290101 · DOI · Paper page
10.1161/01.CIR.87.1.1 · DOI · Paper page
10.1056/NEJM200103223441202 · DOI · Paper page
Loeb HS, Johnson G, Henrick A, et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87: VI78–VI87.
10.1056/NEJM198808183190701 · DOI · Paper page
10.1016/j.ahj.2003.12.040 · DOI
10.1016/0002-9149(90)90937-V · DOI · Paper page
10.1056/NEJM199610103351504 · DOI · Paper page
10.1016/0735-1097(94)00428-S · DOI
10.1016/S0002-8703(96)90537-2 · DOI
10.1016/0002-9149(88)90015-X · DOI
10.1161/01.CIR.85.4.1364 · DOI · Paper page
Packer M. Hemodynamic consequences of antiarrhythmic drug therapy in patients with chronic heart failure. J Cardiovasc Electrophysiol. 1991; 2: S240–S247.
10.1056/NEJM199909163411201 · DOI · Paper page
Packer M, Kessler PD, Lee WH. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far. Circulation. 1987; 75: V56–64.
Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia. Am J Med. 1986; 80: 23–9.
10.1016/S0272-6386(87)80014-8 · DOI
10.1016/0002-9149(86)90884-2 · DOI
10.1016/0002-9149(90)90959-5 · DOI
10.1177/000331977802900302 · DOI
10.1016/0002-9149(89)90216-6 · DOI
10.1056/NEJM199511023331806 · DOI · Paper page
10.1016/S0002-8703(98)70310-2 · DOI
10.1016/S0735-1097(97)00208-8 · DOI · Paper page
10.1046/j.1525-1497.1999.00291.x · DOI
10.1023/A:1011119003788 · DOI · Paper page
10.1161/circ.102.6.611 · DOI
10.1161/circ.80.6.2598430 · DOI
10.1056/NEJM198104023041401 · DOI · Paper page
10.1001/jama.1982.03320370021023 · DOI · Paper page
10.1161/circ.72.4.2863012 · DOI
10.1016/0002-9149(90)90308-N · DOI
Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 1992; 85: I50–6.
10.1111/j.1540-8159.1998.tb00119.x · DOI
10.1161/circ.82.4.2144796 · DOI
10.1016/S0140-6736(96)02149-6 · DOI · Paper page
10.1016/S0002-9149(98)00006-X · DOI
10.1161/circ.91.2.462 · DOI
10.1016/S0140-6736(94)91895-3 · DOI · Paper page
10.1056/NEJM199507133330201 · DOI · Paper page
10.1161/circ.93.12.2128 · DOI
10.1056/NEJMoa033088 · DOI · Paper page
10.1161/circ.104.6.664 · DOI
10.1016/S0002-9149(99)80581-5 · DOI
10.1016/S1071-9164(99)90019-2 · DOI
10.1016/0002-9149(88)90225-1 · DOI
10.1161/circ.79.4.2924415 · DOI
10.1136/hrt.66.6.443 · DOI
10.1016/0002-9343(74)90604-4 · DOI
10.1016/0002-8703(91)90832-3 · DOI
10.1016/S0002-8703(99)70107-9 · DOI
Cadel A, Brusoni B, Pirelli P, et al. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure. Arzneimittelforschung. 1986; 36: 376–9.
10.1016/0735-1097(93)90473-E · DOI
10.1016/S0735-1097(84)80044-3 · DOI
10.1136/hrt.53.2.208 · DOI
10.1016/0002-9149(91)90356-P · DOI
10.1161/circ.71.5.3886191 · DOI
10.1016/0002-8703(91)90154-A · DOI
10.1161/circ.69.5.6142775 · DOI
10.1161/circ.82.3.2144216 · DOI
10.1016/0735-1097(93)90579-P · DOI
10.1161/circ.66.6.6128086 · DOI
10.1056/NEJM199812173392503 · DOI · Paper page
10.1136/hrt.72.3.226 · DOI
10.1056/NEJM199307153290301 · DOI · Paper page
10.1016/S0140-6736(96)10488-8 · DOI · Paper page
10.1136/hrt.76.3.223 · DOI
10.1056/NEJM199111213252103 · DOI · Paper page
10.1016/S0002-8703(98)70352-7 · DOI
10.1016/S0033-0620(98)80056-X · DOI
10.1016/S0002-8703(96)90315-4 · DOI
10.1016/0002-8703(87)90757-5 · DOI
10.1016/S0009-9236(98)90092-3 · DOI
10.1038/clpt.1980.148 · DOI
10.1016/0735-1097(96)00161-1 · DOI · Paper page
10.1016/S0009-9236(97)90067-9 · DOI
Faris R Flather MD Purcell H et al. Diuretics for heart failure. Cochrane Database Syst Rev. 2006;CD003838. · DOI
10.1016/j.jacc.2005.05.099 · DOI
10.1016/S0735-1097(03)00765-4 · DOI · Paper page
10.1016/S0735-1097(02)01965-4 · DOI

200 of 317 shown

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., Hohnloser, S. H., Nichol, G., Birnie, D. H., Sapp, J. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009540 · Cited by 1,859
Epidemiology of Heart Failure
Roger, V. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.300268 · Cited by 1,728
Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease
Corsten, M. F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., Wagner, D. R., Staessen, J. A., Heymans, S., & Schroen, B. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.957415 · Cited by 794
Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts
Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Zile, M. R., Gottdiener, J. S., Hetzel, S. J., McMurray, J. J., Komajda, M., McKelvie, R., Baicu, C. F., Massie, B. M., & Carson, P. E. (2011) · Circulation · doi:10.1161/circulationaha.110.011031 · Cited by 517

See all 1,419

Authors: 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE, Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., & Yancy, C. W.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-04-14
Volume: 119
Issue: 14
Pages: 1977-2016
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.109.192064
OpenAlex: W2614343168
Cited by: 1,419
References: 26
FWCI: 118.83
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review